Oral montelukast in patients with acute severe asthma Source: Annual Congress 2007 - Recent advances in our understanding of the treatment of asthma Year: 2007
Cardiovascular safety of high doses of the nebulized bronchodilators in acute severe asthma Source: Eur Respir J 2004; 24: Suppl. 48, 541s Year: 2004
Nebulizer therapy with budesonide in addition to systemic corticosteroids in acute severe asthma Source: Eur Respir J 2004; 24: Suppl. 48, 541s Year: 2004
The management of acute asthma with and without the administration of aminophylline Source: Eur Respir J 2006; 28: Suppl. 50, 314s Year: 2006
Efficacy and safety of intravenous montelukast in patients with acute exacerbations of bronchial asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008
Treating acute severe asthma attacks in children: using aminophylline Source: Breathe, 16 (4) 200081; 10.1183/20734735.0081-2020 Year: 2020
Oral corticosteroids in the treatment of exacerbation of severe asthma Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden Year: 2020
The impact of preventive treatment with long-acting β2 adrenergics agonists and inhaled glucocorticoids in the morbility and mortality of 1.543 events of severe acute exacerbations of asthma Source: Annual Congress 2009 - Epidemiology of atopy and asthma Year: 2009
Bronchodilator therapies for severe asthma Source: Eur Respir Mon 2011; 51: 253-267 Year: 2011
Utility of aerosolized budesonide therapy in acute moderate exacerbations of asthma Source: Eur Respir J 2003; 22: Suppl. 45, 283s Year: 2003
An economic evaluation of adding inhaled corticosteroids to systemic corticosteroids for treating acute asthma exacerbations Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019
Treatment of acute asthma Source: Eur Respir Mon 2012; 56: 172-187 Year: 2012
Clinical efficacy of nebulised budesonide in acute exacerbation of COPD Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010
Severe exacerbations, decline in lung function and inhaled budesonide in asthma Source: Eur Respir J 2007; 30: Suppl. 51, 619s Year: 2007
Effect of budesonide/formoterol, budesonide and terbutaline on exercise-induced bronchoconstriction in mild intermittent asthma Source: Annual Congress 2011 - Asthma management and response Year: 2011
Efficacy of nebulised adrenaline and salbutamol on mild to moderate bronchiolitis Source: Annual Congress 2003 - New perspectives in bronchiolitis Year: 2003
Aerosolized budesonide therapy in acute moderate exacerbations of Indian asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 343s Year: 2004
Rescue-free days in patients with mild persistent asthma receiving montelukast sodium or an inhaled corticosteroid Source: Eur Respir J 2002; 20: Suppl. 38, 113s Year: 2002
Corticosteroid sensitivity in patients with chronic obstructive pulmonary disease is restored by theophylline Source: Annual Congress 2005 - Therapeutic options for COPD: present and future Year: 2005
The role of nebulised budesonide in the treatment of exacerbations of COPD Source: Eur Respir J 2007; 29: 660-667 Year: 2007